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Available online 11 February 2016Methionine restriction (MR) extends the lifespan of awide variety of species, including rodents, drosophila, nem-
atodes, and yeasts. MR has also been demonstrated to affect the overall growth of mice and rats. The objective of
this study was to evaluate the effect of MR on bone structure in young and agedmale and female C57BL/6J mice.
This study indicated that MR affected the growth rates of males and young females, but not aged females. MR
reduced volumetric bone mass density (vBMD) and bone mineral content (BMC), while bone microarchitecture
parameters were decreased in males and young females, but not in aged females compared to control-fed (CF)
mice. However, when adjusted for bodyweight, the effect of MR in reducing vBMD, BMC and microarchitecture
measurements was either attenuated or reversed suggesting that the smaller bones in MR mice is appropriate
for its body size. In addition, CF andMRmice had similar intrinsic strength properties asmeasured by nanoinden-
tation. Plasma biomarkers suggested that the low bonemass inMRmice could be due to increased collagen deg-
radation, whichmay be inﬂuenced by leptin, IGF-1, adiponectin and FGF21 hormone levels. Mouse preosteoblast
cell line cultured under low sulfur amino acid growth media attenuated gene expression levels of Col1al, Runx2,
Bglap, Alpl and Spp1 suggesting delayed collagen formation and bone differentiation. Collectively, our studies
revealed that MR altered bone morphology which could be mediated by delays in osteoblast differentiation.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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MC3T3-E1 subclone 41. Introduction
Methionine restriction (MR) extends the lifespan of awide variety of
species, including rodents, drosophila, nematodes, and yeasts (Brown-
Borg et al., 2014; Cabreiro et al., 2013; Johnson and Johnson, 2014; Lee
et al., 2014; Miller et al., 2005; Orentreich et al., 1993; Richie et al.,
1994; Ruckenstuhl et al., 2014). Lifespan extension by MR in rodents
could be due to several factors, including: 1) delays in age-related dis-
eases, such as obesity and diabetes (Ables et al., 2012; Perrone et al.,
2008; Plaisance et al., 2011; Stone et al., 2014); 2) decreasedsurface; BV, bone volume; CF,
inal telopeptide of type 1 colla-
HHCy, hyperhomocysteinemia;
actor-1; Imax, maximalMOI; Imin,
tia; MR, methionine restriction;
ropeptide of type 1 procollagen;
actor κB ligand; SMI, structure
aration; Tb.Th, trabecular thick-
ensity; μCT, micro-computed
e Advancement of Science, Inc.,
. This is an open access article undermitochondrial oxidative stress (Caro et al., 2008, 2009;
Sanchez-Roman and Barja, 2013); and 3) reduced risk for cancer pro-
gression (Komninou et al., 2006; Lu et al., 2002; Sinha et al., 2014). In
addition to the beneﬁcial effects of MR, this diet also reduces the body
size of mice and rats (Ables et al., 2012; Huang et al., 2014).
To our knowledge, there are only two previous studies that investi-
gated the effects of MR in bones of young growing male mice and rats
(Ables et al., 2012; Sinha et al., 2014). We previously reported that
mice provided a high-fatmethionine-restricted diet (HFD-MR) exhibited
growth restriction compared to their HFD-CF (control-fed) counterparts,
which could be due to increased collagen degradation (Ables et al.,
2012). The HFD-MR mice had smaller femurs with reduced bone mass
density (BMD) and bone mineral content (BMC) compared to HFD-CF
mice (Ables et al., 2012). Huang et al. reported thatMR ratswere smaller;
had reduced bone mass compared to CF rats, as determined by micro-
computed tomography (μCT); and had decreased extrinsic strength, as
measured by a 3-point bending test (Huang et al., 2014). However,
bones fromMR rats had higher intrinsic biomaterial strength and tough-
ness compared to CF rats (Huang et al., 2014). These studies suggest that
MR affects overall bone development in rodents.
A salient characteristic of MR is its ability to induce hyperhomocys-
teinemia (HHcy) in rodents due to decreased cystathionine β-synthase
(CBS) activity (Ables et al., 2015; Elshorbagy et al., 2010). Interestingly,the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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alter cardiac function in MR mice (Ables et al., 2015). In addition,
Tyagi et al. reported that HHcy in mice reduced bonemass and affected
bone remodeling due to altered bone blood ﬂow (Tyagi et al., 2011).
Furthermore, Vijayan et al. reported that HHCy induced alterations in
osteoprotegerin/RANKL ratio suggesting increased osteoclast activity
which could lead to bone loss (Vijayan et al., 2013). Our current studies,
however, focused on the effects of MR in bonemetabolismwhich could
be indirectly affected by HHCy.
The potential to translate the beneﬁts of MR into the clinical setting
due to its favorable effects with regard to the prevention of diabetes,
obesity, and cancer is increasing (Ables et al., 2012; Perrone et al.,
2008; Plaisance et al., 2011; Komninou et al., 2006; Sinha et al., 2014;
Lu et al., 2003).
To contribute to the overall understanding of MR, we conducted a
study on its effects on bone growth and development. Our current
study focused on the bones of young and aged mice. Importantly, our
studies addressed whether gender is a factor in the effects of MR,
which has not been fully explored in the ﬁeld of bone biology. Finally,
we identiﬁed a potential molecular mechanism of MR in bones using
MC3T3-E1 preosteoblast cell line.
2. Materials and methods
2.1. Animal care
All of the experiments were approved by the Institutional Animal
Care and Use Committee of the Orentreich Foundation for the Advance-
ment of Science, Inc. (Permit Number: 0511MB). Male and female
C57BL/6J (Stock#000664)micewere purchased from Jackson Laborato-
ries (Bar Harbor, ME, USA) and individually housed in a conventional
animal facilitymaintained at 20±2 °C and a 50±10% relative humidity
with a 12 h light: 12 h dark photoperiod. Youngmales and femaleswere
8 weeks old at the initiation of the experiments and 20 weeks old upon
termination. Aged male and female mice (retired breeders from the
Jackson Laboratories) were 9 months old at the initiation of the experi-
ments and 12 months old upon termination. Food and water were pro-
vided ad libitum. The diet ingredients and feeding protocol have been
described previously (Ables et al., 2012, 2015). Brieﬂy, upon arrival,
the mice were acclimatized for one week and fed Purina Lab Chow
#5001 (St. Louis, MO, USA). Afterwards, they were weight matched
and separated into either CF (0.84%methioninew/w) orMR (0.12%me-
thionine w/w) diets consisting of 14% kcal protein, 76% kcal carbohy-
drate, and 10% kcal fat (Research Diets, New Brunswick, NJ, USA) for
12 weeks. The diet compositions are shown in Supplementary Table 1.
Body weight and food consumption were monitored twice weekly. On
the day of sacriﬁce, animals were fasted for 4 h at the beginning of the
light cycle to establish a physiological baseline. Mice were sacriﬁced
by CO2 asphyxiation. Blood was collected from the retro-orbital plexus,
and plasma was collected, ﬂash frozen, and stored at −80 °C until
analyzed.
2.2. Animal measurements and bone sample preparation
Under light isoﬂurane anesthesia, length measurements were
made from the tip of the nose to the base of the tail of each
mouse every 4 weeks for young mice and every 2 weeks for aged
mice. After sacriﬁce, the bones were separated from the soft tissue
and processed as described previously (Ables et al., 2012; Huang
et al., 2014). Brieﬂy, the tibiae were stored in 70% ethanol for μCT
scanning. The femur length was measured using a caliper ruler
from the head of the femur to the distal condyle. The bones were
then cleaned of soft tissue, wrapped in gauze, immersed in PBS
(pH 7.4), and stored in aluminum foil at −80 °C for nanoindenta-
tion test. Bones were collected according to different tests, as
described below.2.3. Micro-computed tomography (μCT) analysis
Bone histomorphometry was conducted as described previously
(Huang et al., 2014). Brieﬂy, tibiae that were subjected to μCT scanning
(SkyScan 1176, SkyScan, Belgium) using the following parameters:
Al 0.5-mm ﬁlter, 48 kV, 200 μA, 1° rotation step per picture with
2600 ms exposure time, and 9 μm pixel size. Cross-section images (8-
bit BMP ﬁle) were reconstructed using NRecon (version 1.6.9.4,
SkyScan, Belgium) with the following parameters: dynamic range =
0–0.13, smoothing = 2, ring artifact correction = 6, and beam harden-
ing correction (%) = 22. Various densitometry and histomorphometry
analyseswere performed using CT-Analyzer (version 1.12.0.0; SkyScan)
with the gray threshold consistently selected over a range of 50–255.
Volumetric bonemass density (vBMD, g/cm3) andbonemineral content
(BMC, mg) measurements were conducted on the whole tibiae,
midshaft cortical bones (transverse slices of 1 mm in thickness), and
secondary spongiosa of each tibia (transverse slices between 0.5 and
2.5 mm below the lowest point of the growth plate at the distal
metaphysis without cortical bone). The following were measured in
secondary spongiosa: histomorphometric indices of bone volume (BV,
mm3) and the BV to total volume (TV) ratio (BV/TV, %), bone surface
(BS, mm2), BS to BV ratio (BS/BV, 1/mm), trabecular thickness (Tb.Th,
mm), trabecular number (Tb.N, 1/mm), trabecular separation (Tb.Sp,
mm), connectivity density (Conn.Dn., 1/mm3), and structure model
index (SMI). In addition, a transverse-CT slice was acquired to assess
cross-sectional parameters, including the bone area (mm2) and 3
indices of cross-sectional moment of inertia (MOI): polar MOI (pMOI),
maximal MOI (Imax), and minimal MOI (Imin).
2.4. Bone material testing by nanoindentation
The material level intrinsic properties were assessed using a
nanoindentation system (MTS/Agilent XP, Santa Clara, CA, USA)
consisting a 60 ± 5° diamond conical indenter with a radius of
2 μm at the tip (Dubois-Ferriere et al., 2014). In brief, femurs were
thawed at room temperature, glued to an aluminum stage, and
moistened with PBS (pH 7.4) solution for the indentation test. The
test was performed on the posterior cortical bone surface at the
midshaft of the femur. For each indentation location, two identical
trials were performed using the following protocol: ultimate load
of 100 milli-Newtons (mN), loading/unloading rate of 1 mN/s, and
ultimate-load holding time of 30 s. After 5 min of recovery for the
viscoelastic property, a second identical test was conducted on the
same location. The indentation hardness (H) and modulus (E) were
calculated using the following equations:
H ¼ P=A
E ¼ 1
2
∙
ﬃﬃﬃ
π
p
ﬃﬃﬃ
A
p ∙ dP
dh
where H is hardness, P is the indentation load, A is the projected contact
area, E is the indentation modulus, and dPdh is the maximal slope of
the unloading curve. In addition, the distance between two ulti-
mate load depths and two indentations on the same location was
measured as the indentation depth increase (IDI, nm) (Hansma
et al., 2008). For each femur sample, the repetitive indentation
trial was conducted in two locations at a distance of 0.5 mm from
each other.
2.5. Blood biochemical tests
ELISA kits were used to detect the N-terminal propeptide of type 1
procollagen (P1NP), C-terminal telopeptide of type 1 collagen (CTX-1)
(Immunodiagnostic Systems, Fountain Hills, AZ), receptor activator for
nuclear factor κB ligand (RANKL), leptin, insulin-like growth factor-1
35A. Ouattara et al. / Bone Reports 5 (2016) 33–42(IGF-1), adiponectin (R&D Systems, Minneapolis, MN, USA); and ﬁbro-
blast growth factor-21 (FGF-21, Millipore Corp., Billerica, MA, USA).
Multiplex analysis was conducted using a Luminex 200 system at the
Human Immune Monitoring Core at Mount Sinai Icahn School of Medi-
cine (New York, NY) using the metabolites for osteoprotegerin (OPG)
and osteocalcin (OC, MBNMAG-41K, Millipore Corp.).2.6. Cell culture experiments
Mouse preosteoblast cell line MC3T3-E1 subclone 4 derived from
murine calvaria was purchased from the American Type Culture Collec-
tion (CRL-2593, ATCC,Manassas, VA). Cells were cultured inα-modiﬁed
Eagle's medium (α-MEM) containing 10% fetal bovine serum (FBS)
(ATCC) under 37 °C in a humidiﬁed atmosphere of 5% CO2. Cells were
passaged every 3 days using Trypsin-EDTA (30–2101, ATCC). For exper-
iments, low passage cells were plated at a density of 5 × 105/cm2 for
24 h until 80% conﬂuent; cells were washed once with PBS solution
and experimental culture media was added. To limit other amino
acids in the experimental culture media, dialyzed FBS was used, as de-
scribed previously (Ramalingam et al., 2010; Skrovanek et al., 2007).
To differentiate cells into osteoblasts, 50 μg/ml ascorbic acid (Sigma)
and 10 mM β-glycerophosphate (Sigma), were added to the culture
media, as described previously (Wang et al., 1999; Xiao et al., 1997).
For control media (CF), α-MEM (A10490 Thermo Fisher, Grand Island,
NY) was used as complete media containing 100 mg/L cysteine,
31 mg/L cystine, and 15 mg/L methionine supplemented with 10% dia-
lyzed FBS (Thermo Fisher). To mimic the MR diet in mice, sulfur amino
acid restricted (SAAR) media was created from complete media diluted
with custom α-MEM without cysteine, cystine, and methionine
(Thermo Fisher). The ﬁnal concentration of sulfur amino acids in
the SAAR media was cysteine 20 mg/L, cystine 6.2 mg/L, and methi-
onine 3 mg/L. Fresh media was added to the cells every 3 days.
When cells were cultured in low methionine media in the absence
of cysteine and cystine, a low rate of survival was observed (data
not shown).2.7. Gene expression analysis
For gene expression analysis in cells, Trizol (LifeTech) was added to
each well of a 6-well cell culture plate following 2washes of PBS at 24 h
and 6 days after plating. Isolation of RNA from whole bones was con-
ducted as described previously (Carter et al., 2012). Brieﬂy, ice-cold
Trizol was added to frozen whole bones and homogenized using
Polytron (Kinematica, Bohemia, NY). Qiagen RNA isolation kits (Qiagen,
Valencia, CA) were used to purify RNA from cells and bones. cDNA was
prepared as described previously (Ables et al., 2012) and TaqMan
quantitative PCR was conducted using primers for Alkaline Phos-
phatase (Alpl, Mm00475834_m1), Bone gamma carboxyglutamate
or osteocalcin (Bglap, Mm03413826_mH), Collagen Type 1, alpha 1
(Col1a1, Mm00801666_g1), Collagen Type 2, alpha 1 (Col2a1,
Mm01309565_m1), Runt-related transcription factor 2 (Runx2,
Mm00501584_m1), and Secreted Phosphoprotein 1 or Osteopontin
(Spp1, Mm00436767_m1). Gene expression was assessed by the
comparative CT (ΔΔCT) method with β-actin as the reference
gene; fold change was based on 24 h CF treated cells.2.8. Statistical analyses
Data are presented as themean± standard deviation (SD). Compar-
isons between the two groups were conducted using ANOVA with a
Bonferroni post hoc test for time course studies or Student's unpaired
t-tests for endpoint analyses. All analyses were performed using Prism
6 (GraphPad Software, La Jolla, CA, USA).3. Results
3.1. Variable effects of MR on growth in young and aged male and female
mice
To determine whether the effects of the MR diet on mouse body
mass are age- and/or gender-related, we conducted studies in young
and aged male and female mice that were fed CF and MR diets for
12 weeks. Our present data are consistent with our previous studies
(Ables et al., 2012, 2015) in which young male MR mice had lower
body weights after 12 weeks on diet (Fig. 1A, P b 0.001). In addition,
young MR female and aged MR male mice had lower body weights
than their CF counterparts (Fig. 1B and C, P b 0.001). On the other
hand, aged female CF and MR mice maintained similar body weights
for the duration of the study (Fig. 1D). Body length measurements re-
vealed that young and aged male and young female MR mice were
smaller than their CF counterparts (Fig. 1E–G, P b 0.05). Aged CF and
MR female mice had similar body lengths for the duration of the study
(Fig. 1H). The femur lengths of young male and female MR mice were
shorter than their CF counterparts (Fig. 1I and J, P b 0.01), while the
femur lengths of aged male and female CF and MR were similar
(Fig. 1K and L). Our previous studies showed increased food consump-
tion per gram body weight in young male MR mice (Ables et al., 2012,
2015), and we observed similar increases in food consumption in
young MR female and aged MR male and female mice (Supplementary
Fig. 1, P b 0.001).
3.2. The MR diet altered volumetric bone mass density (vBMD) and bone
mineral content (BMC) in mice
We next examined whether vBMD and BMC were affected by MR.
Bone densitometry measurements indicated that cortical vBMD was
lower in both groups of males and aged female MR mice than their CF
counterparts (Fig. 2A, C, and D, P b 0.05), but not in young females
(Fig. 2B). Trabecular vBMD was lower in young MR mice and aged fe-
male MR mice compared to their CF counterparts (Fig. 2A, B, and D,
P b 0.01), but not in aged MR males (Fig. 2C). Total vBMD in all MR
mice was lower compared to their respective CF counterparts
(Fig. 2A–D, P b 0.01). In BMC, cortical and total BMC were lower in all
MR mice than their CF counterparts (Fig. 2E–F, P b 0.05). Trabecular
BMC was lower in young MR mice (Fig. 2E and F, P b 0.001), while
aged CF and MR mice were similar to each other (Fig. 2G and H).
When adjusted for body weight, cortical, trabecular and total vBMD
were higher in both age groups of MRmales compared to their CF coun-
terparts (Tables 1 and 2, P b 0.001). Cortical and total vBMDwere higher
in youngMR female while trabecular vBMDwas not (Table 1, P b 0.01).
No differences were observed in vBMD and BMC parameters in aged
female mice (Table 2). BMC measurements in both age groups of MR
males were higher compared to their CF counterparts (P b 0.05) while
all BMC parameters remained the same in both age groups of female
mice (Tables 1 and 2).
3.3. MR affected bone microarchitecture
We next tested whether MR affects themicroarchitecture of mice as
measured by micro-computed tomography (μCT). When adjusted for
body weight, μCTmeasurements indicated that trabecular bone volume
(BV), bone volume to trabecular volume ratio (BV/TV) and bone surface
(BS) were lower (P b 0.05) while bone surface to trabecular volume
ratio (BS/TV), structural model index (SMI), trabecular thickness
(Tb.Th), trabecular space (Tb.Sp) were higher (P b 0.01) in young
male MR mice compared to CF counterparts (Table 3). In addition, BS/
TV in young females was higher in MR compared to CF (P b 0.01,
Table 3). Aged MR males had lower BS and trabecular number (Tb.N)
while BS/TV and SMI were higher compared to the CF group
(P b 0.01), while all parameters in aged females were similar between
Fig. 1.MR altered growth and body size in young and aged male and female mice. Bodyweights weremeasured during the course of the study for young males and female (A and B) and
agedmale and female mice (C and D) on CF (open circles) and MR (black dots) diets. Body length measurements from the tip of the nose to the base of the tail were measured in young
male and female (E and F) and agedmale and female (G andH)mice. Femur lengthsweremeasured at the end of the diet studies fromyoungmale and female (I and J) and agedmale and
female (K and L)mice onCF (white bars) orMR (black bars). Statistical analysiswas conductedusing 2-ANOVAwith Bonferroni post hoc tests for time-course studies or Student's unpaired
t-test for endpoint comparisons between 2 groups (n= 7–8/group, *P b 0.05, **P b 0.01, ***P b 0.001).
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bodyweight, our data showed thatMR reduced bonemicroarchitecture
which was more pronounced in young males than young females and
aged males while no effect was observed in aged females (Supplemen-
tary Tables 2 and 3). Representative images are depicted in Supplemen-
tary Fig. 2.
3.4. Intrinsic strength was preserved following MR diet
Our previous study in rats showed that MR reduced femoral extrin-
sic bending strength, butwith increased intrinsic properties when com-
pared to CF cohorts (Huang et al., 2014). In addition, after adjustment
for bodyweight, femurs fromovariectomized (OVX)MR rats had higher
stiffness compared toOVXCF cohorts (Huang et al., 1985). These studies
suggest that the reduced bone strength of MR is size-related and could
be independent of bone material properties. Thus, in the present
study, we used nanoindentation tests to directly measure material
properties of the bone at the tissue level without the inﬂuence of size,
shape, and porosity (Rodriguez-Florez et al., 2013). Our data indicatedthat the indentation depth increase (IDI), hardness, and modulus were
similar in young and aged male and female mice on CF and MR diets
(Fig. 3A–C).
3.5. MR modiﬁed plasma hormone levels of mice
We next examined whether MR affected the hormones that are in-
volved in bonemetabolism as well as the hormones that are commonly
affected by the diet (Table 5). We previously determined that the colla-
gen synthesis marker P1NP and the collagen degradationmarker CTX-1
were affected in HFD-MRmice (Ables et al., 2012). Our current data in-
dicate that the P1NP levels were similar in young CF and MR mice and
were elevated in aged MR mice compared to aged CF mice (P b 0.05).
CTX-1 levels were elevated in young MR and aged male MR mice
(P b 0.01), while the levels were similar in aged females.
Plasma RANKL levels were reduced in young and aged MR females
(P b 0.05),while they remained similar in aged CF andMRmales. Plasma
OPG levelswere reduced inMRmales (P b 0.05),were elevated in young
MR females (P b 0.05), andwere similar in aged CF andMR females. The
Fig. 2.MR diet decreased vBMD and BMC inmice. Bone densitometry was analyzed by μCT inmice fed either CF (white bars) orMR (black bars) diets. Cortical, trabecular and total vBMD
and BMC in youngmales (A and E, respectively), young females (B and F, respectively), agedmales (C andG, respectively), and aged females (D andH, respectively). Statistical analysiswas
conducted using Student's unpaired t-test (n= 7–8/group, *P b 0.05, **P b 0.01, ***P b 0.001). vBMD, volumetric bone mineral density, BMC, bone mineral content CF, control-fed; MR,
methionine restriction.
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male MR 4.6% ± 1.1%, P b 0.05; female CF 10% ± 3.9% vs. female MR
4.8% ± 2.3%, P b 0.05) and was similar in aged CF and MR mice (male
CF 6.4% ± 4.4% vs. male MR 8.1% ± 2.4%; female CF 15% ± 4.7% vs. fe-
male MR 11% ± 3.4%).
We next assessed whether the hormones that are commonly affect-
ed by MR, such as leptin, IGF-1, adiponectin, and FGF21 (Miller et al.,
2005; Ables et al., 2012, 2015; Ducy et al., 2000; Kajimura et al., 2013;
Rosen et al., 2004; Wei et al., 2012), were regulated in our cohorts.
Our data indicate that leptin levels were reduced in MR males
(P b 0.01), but remained similar in CF and MR females. Additionally,
IGF-1was reduced (P b 0.01),while adiponectin and FGF21were elevat-
ed (P b 0.05 for both hormones) inMRmice compared to CFmicewhichwas consistent with our previous data (Miller et al., 2005; Ables et al.,
2012, 2015).
3.6. MR downregulated collagen formation and bone differentiation genes
To gain insight on the possiblemolecularmechanism ofMR in bones
we used mouse preosteoblast cell line, MC3T3-E1 subclone 4 as de-
scribed previously (Quarles et al., 1992; Franceschi et al., 1994). Gene
expression markers for collagen formation and bone differentiation
remained similar between CF and SAAR treated cells after 24 h in culture
(Fig. 4). After 6 days in culture, the molecular signature of CF treated
cells suggests osteoblast differentiation as indicated by the upregulation
of Runx2, Bglap, Spp1, Alpl and Col1a1 (Fig. 4A–E, P b 0.001) genes when
Table 1
Body-weight adjusted vBMD and BMC bones in youngmice following CF andMR diets for
12 weeks. Comparisons between same sex CF and MR were conducted using Student's
unpaired t-test (n= 7–8/group).
Young males Young females
CF MR CF MR
vBMD (mg/cm3) to BW (g)
Cortical 34.4 ± 1.7 50.2 ± 2.9⁎⁎⁎ 48.9 ± 3.4 55.6 ± 2.9⁎⁎
Trabecular 16.8 ± 1.4 22.3 ± 1.1⁎⁎⁎ 25.2 ± 2.7 26.4 ± 1.7
Total 29.2 ± 1.3 42.1 ± 2.4⁎⁎⁎ 42.7 ± 2.7 47.7 ± 2.5⁎⁎
BMC (μg) to BW (g)
Cortical 32.8 ± 3.3 36.8 ± 2.7⁎ 37.1 ± 1.6 36.6 ± 2.3
Trabecular 8.7 ± 2.5 4.5 ± 1.1⁎⁎ 1.9 ± 0.5 1.7 ± 0.4
Total 696 ± 68 770 ± 47⁎ 834 ± 28 812 ± 43
⁎ P b 0.05.
⁎⁎ P b 0.01.
⁎⁎⁎ P b 0.001.
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by the cells as indicated by the similar gene expression levels of
Runx2, Bglap and Col1al (Fig. 4A, B, and E). Spp1 and Alplwere upregulat-
ed in SAAR treated cells after 6 days, but did not reach CF levels of ex-
pression (Fig. 4C and D, P b 0.01). Chondrogenic marker Col2a1 was
similar in CF- and SAAR-treated cells in both time points andwas down-
regulated after 6 days of differentiationwhen compared to 24 h (Fig. 4F,
P b 0.05).
To testwhether the genes thatwere affected byMR in cellswere also
altered in whole bones, we isolated RNA from femurs of agedmales and
females (Supplementary Fig. 3). Gene expression analysis indicated that
Bglapwasdownregulated in agedMRmales compared to its CF counter-
part (Supplementary Fig. 3A). All other genes tested were not affected
by the diet in aged female mice (Supplementary Fig. 3B).
4. Discussion
The aim of the study was to evaluate the effect of MR on bones in
young and aged male and female C57BL/6J mice. Our results indicate
that MR reduces bone mass and alters the bone microarchitecture
while preserving the intrinsic strength of mice. When adjusted for
body weight, our data indicate that the lower bone mass in MR mice
is appropriate for its smaller body size. Our presentwork extends previ-
ous studies on MR mice on HFDs (Ables et al., 2012) and on rats during
exercise (Huang et al., 2014), both of which exhibited reduced bone
mass. In this study, we show variable age- and gender-speciﬁc effects
of MR on bones in mice. Finally, we identiﬁed the possible molecular
mechanism in a mouse preosteoblast cell line, which showed attenuat-
ed levels of gene expression for collagen formation and bone differenti-
ation markers.Table 2
Body-weight adjusted vBMD and BMC bone in agedmice following CF andMRdiets for 12
weeks. Comparisons between same sex CF and MR were conducted using Student's un-
paired t-test (n= 7–8/group).
Aged males Aged females
CF MR CF MR
vBMD (mg/cm3) to BW (g)
Cortical 25 ± 1.9⁎ 34.2 ± 3.1⁎⁎⁎ 41.5 ± 2.6 43 ± 1.7
Trabecular 12.1 ± 0.9⁎⁎ 17.6 ± 1.6⁎⁎⁎ 23.1 ± 1.2 23.1 ± 0.7
Total 21.9 ± 1.4 30.3 ± 2.9⁎⁎⁎ 35.4 ± 2 36.8 ± 1.2
BMC (μg) to BW (g)
Cortical 19.5 ± 1.8 23.5 ± 1.3⁎⁎⁎ 31 ± 2.5 30.3 ± 1.6
Trabecular 1.2 ± 0.3 1.6 ± 0.6 0.7 ± 0.3 0.8 ± 0.5
Total 435 ± 28 527 ± 35⁎⁎⁎ 703 ± 53 663 ± 36
⁎ P b 0.05.
⁎⁎ P b 0.01.
⁎⁎⁎ P b 0.001.The present work indicates that the effects of MR on bone were
comparable to studies conducted using a low-protein diet (LPD) in
rodents (Ammann et al., 2000; Bozzini et al., 2011). Previous studies
that characterized the effects of LPD in rodent bones reduced casein
by 83%, which decreased body weight, bone formation, and bone
mass (Dubois-Ferriere et al., 2014; Bourrin et al., 2000a, b) without
affecting extrinsic bone strength (Dubois-Ferriere et al., 2014).
Other studies manipulated the protein quality (e.g., casein, gluten,
or soy) or concentration and characterized their effects on bones
(Alippi et al., 2012; Rouy et al., 2014). Gluten or a low percentage
of soy protein negatively affected the bone cross-sectional geometry
and structural properties in growing female rats (Alippi et al., 2012).
However, when normalized to body weight, the differences in strength
and stiffness disappeared (Alippi et al., 2012). In addition, a low-soy diet
diminished the femoral cortical thickness, BV, and Tb.N, and Tb.Th and
increased medullar adiposity in growing mice, but it did not affect the
trabecular bone after correcting for body weight (Rouy et al., 2014).
Taken together, these studies suggest that the effects of LPDs in bones
may be due to a concomitant subnormal gain in body weight. Our
data agree with these conclusions, as the observed reductions in the
bone parameters disappeared or were increased in MR mice despite
their small stature.
An important characteristic ofMRwas its effects on the properties of
the bonematerial level. Bozzini et al. suggested that growing female rats
on a LPD reduced themandibular bone structural properties as a conse-
quence of a correlative loss of gain in both growth and mass, but not in
the bone material properties (Bozzini et al., 2011). Additionally, Allipi,
et al. demonstrated that bonematerial quality indicators (elastic modu-
lus, yielding stress, elastic energy absorption/volume)were not affected
by LPDs (Alippi et al., 2012). Furthermore, indirect calculations showed
thatMR rats had higher intrinsic biomechanical strength and toughness
compared to CF rats, suggesting that despite their smaller stature, MR
may be beneﬁcial to bone material properties (Huang et al., 2014). Fi-
nally, ovariectomizedMR rats exhibited larger and stronger biomechan-
ical properties compared to CF counterparts when adjusted for body
weight (Huang et al., 1985). Overall, our data supports previous studies
(Huang et al., 2014, 1985) that showed MR compromised bone mass,
bone size and/or whole bone strength and veriﬁed that, indeed, the
diet does not affect bone material properties.
Bone development is a summary of modeling/remodeling activities,
which are inﬂuenced by hormones that are secreted either by cells
within the tissue or in an endocrine manner. The effects of MR on the
hormones involved in bone remodeling were diverse in our studies.
Our data on P1NP in young mice are consistent with HFD-MR mice,
where the levels were similar in both the CF and MR groups (Ables
et al., 2012). Interestingly, the P1NP levels were higher in aged male
MR mice than aged male CF mice, suggesting more active bone forma-
tion. Consistent with our previous studies, our current data show that
male and young female MR mice had elevated CTX-1 levels, suggesting
that the reduced bonemass could be partially due to increased collagen
degradation (Ables et al., 2012). However, maleMR rats had lower CTX-
1 levels compared to their CF counterparts, demonstrating species dif-
ferences in the hormonal regulation of CTX-1 under MR conditions
(Huang et al., 2014). Therefore, the elevated levels of both P1NP and
CTX-1 suggest active bone remodeling in MRmice, which could explain
the low bone mass phenotype. In contrast to bone speciﬁc markers,
serum RANKL and OPG, which are indirect indices for bone turnover,
did not suggest activated osteoclastogenesis. Because RANKL and OPG
are also expressed by multiple cell types (e.g., B cells and T cells),
which are mediated by immune as well as inﬂammatory responses
(Kearns et al., 2008), the down-regulation of RANKL and OPG was
more likely the result of a collaboration with the multi-regulated phys-
iological system rather than acting as a speciﬁc indicator for bone cell
activities. This is supported by data on the hormones that were affected
by MR, such as IGF-1, the adipokine leptin and adiponectin, and the
hepatokine FGF21. Our data is consistent with previous reports in
Table 3
Body-weight adjusted trabecular andmidshaft bonemicroarchitecture in youngmice following CF andMR diets for 12weeks. Comparisons between same sex CF andMRwere conducted
using Student's unpaired t-test (n= 7–8/group). BV, bone volume; TV, total volume; BS, bone surface; SMI, structure model index; Tb.Th, trabecular thickness; Tb.N trabecular number;
Tb.Sp, trabecular separation; Conn.Dn., connectivity density; MOI, moment of inertia; pMOI, polar MOI; Imax, maximal MOI; Imin, minimal MOI.
Young males Young females
CF MR CF MR
Trabecular bone
BV (mm3) 0.016 ± 0.004 0.009 ± 0.002⁎⁎ 0.003 ± 0.001 0.003 ± 0.001
BV/TV (%) 0.561 ± 0.12 0.382 ± 0.05⁎⁎ 0.176 ± 0.04 0.176 ± 0.04
BS (mm2) 0.721 ± 0.1 0.601 ± 0.09⁎ 0.221 ± 0.05 0.229 ± 0.03
BS/TV (1/mm) 1.49 ± 0.33 3.09 ± 0.39⁎⁎⁎ 2.94 ± 0.25 3.68 ± 0.45⁎⁎
SMI 0.073 ± 0.01 0.128 ± 0.01⁎⁎ 0.142 ± 0.01 0.153 ± 0.01
Tb.Th (mm) 0.0025 ± 0.0 0.0029 ± 0.0⁎⁎⁎ 0.003 ± 0.0 0.003 ± 0.0
Tb.N (1/mm) 0.068 ± 0.01 0.06 ± 0.01 0.024 ± 0.004 0.028 ± 0.006
Tb·Sp. (mm) 0.008 ± 0.002 0.014 ± 0.001⁎⁎⁎ 0.021 ± 0.003 0.022 ± 0.003
Conn.Dn. (1/mm3) 3.3 ± 0.52 3.0 ± 0.43 3.9 ± 2.1 2.8 ± 1.4
Midshaft tibia
Bone area (mm2) 0.029 ± 0.003 0.034 ± 0.002⁎⁎ 0.034 ± 0.002 0.033 ± 0.002
pMOI (mm4) 0.009 ± 0.002 0.01 ± 0.001 0.009 ± 0.001 0.008 ± 0.001
Imax (mm4) 0.005 ± 0.001 0.006 ± 0.001 0.005 ± 0.00 0.004 ± 0.00
Imin (mm4) 0.003 ± 0.001 0.004 ± 0.001 0.004 ± 0.00 0.003 ± 0.00
⁎ P b 0.05.
⁎⁎ P b 0.01.
⁎⁎⁎ P b 0.001.
39A. Ouattara et al. / Bone Reports 5 (2016) 33–42which MR decreased IGF-1 levels in rodents (Ables et al., 2012; Huang
et al., 2014;Malloy et al., 2006; Perrone et al., 2010), MR had less impact
on bone mass and structure in aged female mice, suggesting age- and
gender-speciﬁc alternate pathways of IGF-1 in the bones of MR mice.
Leptin has been shown to increase the osteoblast number and activity
(Turner et al., 2013). Since MR reduced leptin levels in males, but not
in females, could partly explain the low bone mass phenotype (Ducy
et al., 2000; Turner et al., 2013). Adiponectin decreases bone mass by
inhibiting the proliferation of osteoblasts and reducing osteocalcin
levels (Kajimura et al., 2013). However, chronic elevated adiponectin
levels increase bone mass via neuronal activation of the PI3-kinase-
FoxO1 pathway (Kajimura et al., 2013). MR consistently led to elevated
levels of adiponectin in mice, but had varying effects on bones, suggest-
ing its age- and gender-speciﬁc inﬂuence on bonemetabolism. Elevated
FGF21 levels reduce bone mass by inhibiting osteoblastogenesis and
increasing bone marrow adipogenesis via increased peroxisome-
proliferator activator-receptor-gamma activity (Wei et al., 2012). Our
data indicate that elevated FGF21 levels in MR mice could induce lowTable 4
Body-weight adjusted trabecular andmidshaft bonemicroarchitecture in aged mice following C
using Student's unpaired t-test (n= 7–8/group). BV, bone volume; TV, total volume; BS, bone
Tb.Sp, trabecular separation; Conn.Dn., connectivity density; MOI, moment of inertia; pMOI, po
Aged males
CF MR
Trabecular bone
BV (mm3) 0.002 ± 0.001 0.002 ±
BV/TV (%) 0.102 ± 0.03 0.09 ±
BS (mm2) 0.145 ± 0.03 0.138 ±
BS/TV (1/mm) 1.6 ± 0.18 2.49 ±
SMI 0.078 ± 0.01 0.117 ±
Tb.Th (mm) 0.002 ± 0.0 0.003 ±
Tb.N (1/mm) 0.015 ± 0.004 0.013 ±
Tb.Sp (mm) 0.009 ± 0.001 0.016 ±
Conn.Dn. (1/mm3) 0.83 ± 0.3 0.75 ±
Midshaft tibia
Bone area (mm2) 0.019 ± 0.002 0.025 ±
pMOI (mm4) 0.006 ± 0.001 0.008 ±
Imax (mm4) 0.004 ± 0.00 0.005 ±
Imin (mm4) 0.002 ± 0.00 0.003 ±
⁎ P b 0.05.
⁎⁎ P b 0.01.
⁎⁎⁎ P b 0.001.bone mass, at least in young MR and aged MR males, but not in aged
MR females, suggesting an age- and gender-speciﬁc effect of the diet
on development. Collectively, the effects of MR on bones are regulated
by a collaboration of hormones that are secreted by bone tissue and pe-
ripheral organs.
A potential consequence of hormonal regulation on bone remodel-
ing was observed in the changes in the vBMD, bone size, and body
mass of the study groups. In our previous study in MR rats, cross-
sectional measurements of long bones and BMC indices were consis-
tently correlated with body weight, suggesting that smaller bones are
most likely the result of a body size-related phenomenon (Huang
et al., 2014). In addition, our current data indicate thatwhen normalized
for bodyweight, total vBMD and BMCwere higher inmaleMRmice. Be-
cause the body weight of aged females was unchanged for the duration
of the study, it served as a negative control for our experiments. There-
fore, under the currentMR conditions, the animals demonstrated differ-
ent levels of body size as well as bone mass change without further
compromising bone material properties.F andMR diets for 12weeks. Comparisons between same sex CF andMR were conducted
surface; SMI, structure model index; Tb.Th, trabecular thickness; Tb.N trabecular number;
lar MOI; Imax, maximal MOI; Imin, minimal MOI.
Aged females
CF MR
0.001 0.001 ± 0.00 0.001 ± 0.001
0.03⁎ 0.053 ± 0.02 0.06 ± 0.03
0.04⁎⁎ 0.065 ± 0.03 0.069 ± 0.03
0.42⁎⁎⁎ 2.2 ± 0.26 2.35 ± 0.23
0.01⁎⁎⁎ 0.113 ± 0.01 0.118 ± 0.008
0.0 0.003 ± 0.0 0.003 ± 0.0
0.003⁎⁎⁎ 0.007 ± 0.003 0.007 ± 0.004
0.002 0.027 ± 0.002 0.029 ± 0.002
0.32 0.78 ± 0.41 0.43 ± 0.28
0.002 0.029 ± 0.002 0.029 ± 0.002
0.001 0.008 ± 0.001 0.008 ± 0.001
0.00 0.004 ± 0.00 0.005 ± 0.00
0.00 0.004 ± 0.00 0.004 ± 0.00
Fig. 3. Intrinsic strength of bones was similar in CF and MR mice as revealed by
nanoindentation tests. Indentation depth increase (A), hardness (B) and Modulus
(C) were measured in the midshaft region of the femur, as described in the methods
section in mice after 12 weeks of CF (white bars) or MR (black bars) diets. Statistical
analysis was conducted between CF and MR of each age group and gender using
Student's unpaired t-test (n= 5–8/group).
Table 5
Plasma hormone levels of youngmale and femalemice on CF andMR diets for 12 weeks. Compa
7–8/group). P1NP, N-terminal propeptide of type 1 procollagen; CTX-1, C-terminal telopeptide o
growth factor-1; FGF21, ﬁbroblast growth factor-21; OPG, osteoprotegerin; OC, osteocalcin.
Young males Young females
CF MR CF MR
P1NP (ng/ml) 40 ± 8 39 ± 9 42 ± 11 49 ±
CTX-1 (ng/ml) 16 ± 1 25 ± 7⁎⁎ 21 ± 5 33 ±
RANKL (pg/ml) 142 ± 66 77 ± 13⁎ 159 ± 41 100 ±
OPG (ng/ml) 1.9 ± 0.6 1.6 ± 0.2 1.7 ± 0.4 2.2 ±
OC (ng/ml) 31 ± 5 27 ± 2 33 ± 6 39 ±
Leptin (ng/ml) 11 ± 8 0.9 ± 0.3⁎⁎ 1.6 ± 0.7 1.1 ±
IGF-1 (pg/ml) 355 ± 60 182 ± 42⁎⁎⁎ 366 ± 99 209 ±
Adiponectin (μg/ml) 7.7 ± 1.9 15.7 ± 0.9⁎⁎⁎ 14.8 ± 1.3 18.9 ±
FGF21 (ng/ml) 0.82 ± 0.5 6.0 ± 2.1⁎⁎ 0.44 ± 0.2 3.8 ±
⁎ P b 0.05.
⁎⁎ P b 0.01.
⁎⁎⁎ P b 0.001.
40 A. Ouattara et al. / Bone Reports 5 (2016) 33–42Of particular interest, female mice were affected by MR less than
male mice. The use of retired breeder female mice as the aged female
group served as a model for postmenopausal women. Our data on
aged female mice show that body weight and bone microarchitecture
were similar in CF and MR mice. One possible explanation could be
the interference of estrogen, which is also involved in bone remodeling
(Connelly et al., 2015; Henning et al., 2014; Macari et al., 2015). A study
on pregnant women showed high bone turnover which could explain
trabecular bone loss (Naylor et al., 2000). In addition, because the de-
pendence on methionine decreased with aging (Pitkanen et al., 2003),
MR had the lowest impact on the body size and bones of aged female
mice, suggesting that the dosage of MR in aged female mice used in
this studywas not optimal. Therefore, it is recommended that appropri-
ate and carefully titrated dosages of MR in aged females be conducted.
Studies using 40%MR in juvenile rats did not affect growth as repre-
sented by body weight (Sanchez-Roman and Barja, 2013) but nonethe-
less reduced oxidative stressmarkers (Caro et al., 2008; Sanchez-Roman
et al., 2011) when compared to control counterparts. The possible
mechanism is the similar levels of reductions in mtROSp and 8-oxodG
in mtDNA in both MR conditions (Caro et al., 2009). Therefore, future
studies could be directed in determining the effects of 40%MR on bones.
To our knowledge, this is the ﬁrst study that used mouse
preosteoblast cell line MC3T3-E1 subclone 4 under low sulfur
amino acid conditions to identify the molecular mechanism of MR.
MC3T3-E1 cells have been used extensively to characterize and de-
termine molecular mechanisms of osteoporosis in mouse bone
cells (Xiao et al., 1997; Franceschi et al., 1994; Addison et al.,
2015). Additionally, SAAR in cell growth media was established in
renal cell line studies on epithelial tight junctions (Ramalingam
et al., 2010; Skrovanek et al., 2007). These studies enabled us to de-
termine the potential molecular mechanism of MR at the cellular
level. In agreement with previous studies, CF-treated cells showed
upregulation of Runx2, Bglap, Spp1, Alpl and Col1a1 gene expression
markers for osteoblast differentiation (Wang et al., 1999; Beck et al.,
1998; Roca et al., 2005). However, expression for the same differen-
tiation genes in SAAR-treated cells remained similar even after
6 days of culture suggesting its repressed differentiation. In addi-
tion, chondrogenic marker Col2a1 (Oralova et al., 2015) was down-
regulated in both treatment groups after 6 days. Based on our
results, the attenuation of gene expression markers for collagen
formation and bone differentiation in MC3T3-E1 cells under SAAR
conditions suggests delays in bone differentiation and could possibly
explain the reduced bone parameters observed in mice. The effect of
low methionine on bone differentiation was further conﬁrmed when
Bglapwas downregulated in whole bones of aged male MRmice. Over-
all, the possible molecular mechanism of MR could be due to its effects
on genes that affect bone differentiation.risons between same sex CF andMRwere conducted using Student's unpaired t-test (n=
f type 1 collagen; RANKL, receptor activator for nuclear factor κB ligand; IGF-1, insulin-like
Aged males Aged females
CF MR CF MR
15 34 ± 3 44 ± 7⁎⁎ 32 ± 8 41 ± 3⁎
7⁎⁎ 14 ± 2 20 ± 3⁎⁎ 18 ± 4 20 ± 5
30⁎ 122 ± 31 122 ± 50 223 ± 40 179 ± 32⁎
0.4⁎ 2.1 ± 0.6 1.6 ± 0.4⁎ 1.6 ± 0.3 1.7 ± 0.4
7 26 ± 3 28 ± 4 25 ± 2 27 ± 4
0.5 32 ± 14 3.4 ± 1.3⁎⁎⁎ 1.6 ± 0.5 1.3 ± 0.6
47⁎⁎ 674 ± 202 277 ± 80⁎⁎⁎ 414 ± 80 276 ± 32⁎⁎
1.0⁎⁎⁎ 9.8 ± 1.5 11.8 ± 1.7⁎ 11.3 ± 1.1 14.9 ± 1.9⁎⁎
1.1⁎⁎⁎ 0.66 ± 0.5 1.6 ± 0.6⁎ 0.9 ± 0.3 2.6 ± 0.9⁎⁎
Fig. 4. Sulfur amino acid restriction (SAAR) downregulated collagen formation and bone differentiation genes inMC3T3-E1 cells. Mouse preosteoblast cell line, MC3T3-E1 subclone 4were
cultured in either completemedia (CF,white bars) or SAAR (black bars)media containing80% reduced cysteine, cystine andmethionine concentrations as described in themethod section.
TaqMan gene expression analyses for (A) Runx2, (B) Bglap, (C) Spp1, (D) Alpl, (E) Col1a1 and (F) Col2a1 at 24 h and after 6 days incubation. Statistical analysis was conducted using 2-way
ANOVA of both time points between CF and MR (n= 6/group).
41A. Ouattara et al. / Bone Reports 5 (2016) 33–42In conclusion, our study establishes the following effects of MR on
bones: 1) bonemorphology in mice is altered, possibly under hormonal
regulation in an age- and gender-speciﬁc manner, 2) reduced bone
mass in MR mice is relative and appropriate for its body size and does
not impair thematerial-level biomechanical properties and 3) attenuat-
ed gene expression levels for bone differentiation and collagen synthe-
sis in vitro could cause, at least in part, delays in bone formation and
overall growth. Overall, our studies extend the current knowledge of
MR and augment the parameters necessary for clinical trials.
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